Abbonarsi

The proximal serrated polyp detection rate is an easy-to-measure proxy for the detection rate of clinically relevant serrated polyps - 14/10/15

Doi : 10.1016/j.gie.2015.02.044 
Joep E.G. IJspeert, MD 1, Sascha C. van Doorn, MD 1, Ymkje M. van der Brug, BSc 1, Barbara A.J. Bastiaansen, MD 1, 2, Paul Fockens, MD, PhD 1, 2, Evelien Dekker, MD, PhD 1, 2, ⁎
1 Department of Gastroenterology and Hepatology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands 
2 Procolo/Bergman Clinics, Amsterdam, The Netherlands 

∗Reprint requests: Evelien Dekker, MD, PhD, Department of Gastroenterology and Hepatology, Academic Medical Centre, Meibergdreef 9 1105 AZ, Amsterdam, The Netherlands.

Abstract

Background and Aims

The adenoma detection rate (ADR) is the most important surrogate quality parameter for colorectal cancer (CRC) prevention. However, serrated polyps also are precursors of CRC. Large, prospective studies comparing the detection rate of serrated polyps among endoscopists in an era of awareness about the malignant potential of serrated polyps have not yet been performed. We aimed to compare the proximal serrated polyp (PSP) detection rate and the clinically relevant serrated polyp (RSP) detection rate among endoscopists and to analyze the association between these parameters and the ADR.

Methods

Colonoscopy data were retrieved in one expert center between January 2011 and July 2014 by using a structured reporting system, enabling prospective and automatic quality assessment. Endoscopists who performed at least 50 colonoscopies within the timeframe were included for analysis. Multivariate logistic regression was used to compare the ADR, PSP detection rate, and RSP detection rate among endoscopists. The association among these parameters was calculated by using the Pearson r correlation coefficient. All lesions were assessed by an expert pathologist.

Results

In total, 16 endoscopists and 2088 colonoscopies were included for analysis. The PSP detection rate ranged from 2.9% to 18.6% (mean 10.4%) among endoscopists. Corrected for confounders, the odds ratio to detect ≥1 PSP, compared with endoscopists with the highest detection rate, ranged from 0.79 (95% confidence interval [CI], 0.41-1.52) to 0.12 (95% CI, 0.03-0.55). The PSP detection rate was highly correlated with the RSP detection rate (ρ 0.94; P < .001), ranging from 4.3% to 20.9% (mean 13.9%). The PSP detection rate moderately correlated with the ADR (0.55; P = .03), which ranged from 23.2% to 49.2% (mean 35.2%).

Conclusions

The PSP detection rate is widely variable among endoscopists, strongly correlated with the RSP detection rate, and moderately correlated with the ADR. These results suggest a high miss rate of RSPs among endoscopists with low rates of PSP detection. Future research should determine the association between endoscopists’ PSP detection rates and the risk of interval cancer.

Il testo completo di questo articolo è disponibile in PDF.

Abbreviations : ADR, BBPS, CRC, HP, PSP, RSP, SP, SSA/P, TSA


Mappa


 DISCLOSURE: All authors disclosed no financial relationships relevant to this article.
 If you would like to chat with an author of this article, you may contact Dr Dekker at [email protected].


© 2015  American Society for Gastrointestinal Endoscopy. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 82 - N° 5

P. 870-877 - novembre 2015 Ritorno al numero
Articolo precedente Articolo precedente
  • Evaluation of the clinical efficacy of colon capsule endoscopy in the detection of lesions of the colon: prospective, multicenter, open study
  • Yutaka Saito, Shoichi Saito, Shiro Oka, Yasuo Kakugawa, Minori Matsumoto, Hiroyuki Aihara, Ikue Watari, Taiki Aoyama, Sadaharu Nouda, Takanori Kuramoto, Kenji Watanabe, Naoki Ohmiya, Kazuhide Higuchi, Hidemi Goto, Tetsuo Arakawa, Shinji Tanaka, Hisao Tajiri
| Articolo seguente Articolo seguente
  • African Americans should be screened at an earlier age for colorectal cancer
  • Ian M. Paquette, Jun Ying, Shimul A. Shah, Daniel E. Abbott, Shuk-mei Ho

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.